Merck KGaA invests nearly $700 million into venture capital arm M Ventures


This replaces an earlier item that incorrectly reported the company making the investment in M Ventures. It has been corrected.

Merck KGaA MKKGY, +0.76% MRK, said Wednesday it will invest an additional 600 million euros (about $680 million) into its corporate venture capital arm M Ventures over the next five years. That’s the third increase in financial commitment announced by the Germany-based science and technology company since M Ventures’ inception in 2009. “Over the past decade, M Ventures has established itself globally as a leading partner to the biotech and tech venture ecosystems,” said Merck KGaA Chief Executive Belén Garijo.

This article was originally published by Read the original article here.

Previous article: Apple hit by supply crunch, saw iPhone 13 production drop 20% in recent months: report
Next articleWhat’s next for robo-advisers and retirement saving? Join discussion at noon.


Please enter your comment!
Please enter your name here